Establishment of a Gonococcal Antimicrobial Surveillance Programme, in Accordance With World Health Organization Standards, in Côte d'Ivoire, Western Africa, 2014–2017
暂无分享,去创建一个
M. Unemo | T. Wi | H. Fayé-Ketté | M. Dosso | A. Ouattara | A. Yéo | Belinda Kouamé-Blavo | Clarisse E Kouamé | Ahou C Yao | Brigitte D Gbedé | Francis Bazan
[1] M. Unemo,et al. Gonorrhoea treatment failure caused by a Neisseria gonorrhoeae strain with combined ceftriaxone and high-level azithromycin resistance, England, February 2018 , 2018, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.
[2] Monica Lahra,et al. Genetic characterisation of Neisseria gonorrhoeae resistant to both ceftriaxone and azithromycin. , 2018, The Lancet. Infectious diseases.
[3] W. Demczuk,et al. Cooperative Recognition of Internationally Disseminated Ceftriaxone-Resistant Neisseria gonorrhoeae Strain , 2018, Emerging infectious diseases.
[4] A. Amato-Gauci,et al. Overall Low Extended-Spectrum Cephalosporin Resistance but high Azithromycin Resistance in Neisseria gonorrhoeae in 24 European Countries, 2015 , 2017, BMC Infectious Diseases.
[5] Suzanna C Francis,et al. Sexually transmitted infections: challenges ahead. , 2017, The Lancet. Infectious diseases.
[6] M. Unemo,et al. Antimicrobial resistance in Neisseria gonorrhoeae: Global surveillance and a call for international collaborative action , 2017, PLoS medicine.
[7] M. Unemo,et al. Antimicrobial susceptibility in Neisseria gonorrhoeae isolates from five sentinel surveillance sites in Zimbabwe, 2015–2016 , 2017, Sexually Transmitted Infections.
[8] L. Sánchez-Busó,et al. The novel 2016 WHO Neisseria gonorrhoeae reference strains for global quality assurance of laboratory investigations: phenotypic, genetic and reference genome characterization. , 2016, The Journal of antimicrobial chemotherapy.
[9] K. Holmes,et al. Neisseria gonorrhoeae Antimicrobial Susceptibility Surveillance - The Gonococcal Isolate Surveillance Project, 27 Sites, United States, 2014. , 2016, Morbidity and mortality weekly report. Surveillance summaries.
[10] M. Unemo,et al. Failure of Dual Antimicrobial Therapy in Treatment of Gonorrhea. , 2016, The New England journal of medicine.
[11] Marleen Temmerman,et al. Global Estimates of the Prevalence and Incidence of Four Curable Sexually Transmitted Infections in 2012 Based on Systematic Review and Global Reporting , 2015, PloS one.
[12] Magnus Unemo,et al. Current and future antimicrobial treatment of gonorrhoea – the rapidly evolving Neisseria gonorrhoeae continues to challenge , 2015, BMC Infectious Diseases.
[13] M. Unemo,et al. Antimicrobial Resistance in Neisseria gonorrhoeae in the 21st Century: Past, Evolution, and Future , 2014, Clinical Microbiology Reviews.
[14] H. Grosskurth,et al. High Prevalence of Ciprofloxacin-Resistant Gonorrhea Among Female Sex Workers in Kampala, Uganda (2008–2009) , 2014, Sexually transmitted diseases.
[15] M. Unemo,et al. Mitigating the emergence and spread of multidrug- and extensively drug-resistant gonorrhea: is there sufficient support in resource-poor settings in Africa? , 2014, Sexually transmitted diseases.
[16] D. Lewis. Global resistance of Neisseria gonorrhoeae: when theory becomes reality , 2014, Current opinion in infectious diseases.
[17] M. Fonkoua,et al. Gonococcal antimicrobial resistance: perspectives from the African region , 2013, Sexually Transmitted Infections.
[18] M. Unemo,et al. Phenotypic and genetic characterization of the first two cases of extended-spectrum-cephalosporin-resistant Neisseria gonorrhoeae infection in South Africa and association with cefixime treatment failure. , 2013, The Journal of antimicrobial chemotherapy.
[19] F. Martinson,et al. Neisseria gonorrhoeae Antimicrobial Susceptibility in Lilongwe, Malawi, 2007 , 2010, Sexually transmitted diseases.
[20] M. Unemo,et al. Phenotypic and genetic characterization of the 2008 WHO Neisseria gonorrhoeae reference strain panel intended for global quality assurance and quality control of gonococcal antimicrobial resistance surveillance for public health purposes. , 2009, The Journal of antimicrobial chemotherapy.
[21] P. Ghys,et al. Increasing Resistance of Neisseria gonorrhoeae in West and Central Africa: Consequences on Therapy of Gonococcal Infection , 1997, Sexually transmitted diseases.